Navigation Links
Diamyd(R) Study Published in Prestigious New England Journal of Medicine
Date:10/9/2008

results are considered to be of such quality and clinical value strengthens our position in the medical and industrial worlds," says Elisabeth Lindner, president and CEO of Diamyd. "We are now moving forward preparing the market introduction of Diamyd(R)."

About the article:

"GAD Treatment and Insulin Secretion in Recent-Onset Type 1 Diabetes"

J Ludvigsson et al., N Engl J Med 2008;359 (Epub ahead of print 10.1056/NEJMoa0804328)

About Diamyd(R) Type 1:

Diamyd(R) Type 1 is the treatment of recently diagnosed patients with the Diamyd(R) diabetes vaccine. Diamyd(R) Type 1 is a simple treatment without any serious side effects. This treatment is now being tested in Phase III studies in Europe and the US. The company plans to complete the application for market approval in late 2010. The annual market for Diamyd(R) Type 1 is estimated at about one billion dollars.

About the mechanism of action:

Type 1 diabetes is an autoimmune disease in which the body's own immune system attacks the cells in the body that produce insulin. The active ingredient in Diamyd(R) is glutamic acid decarboxylase (GAD), which is a dominant antigen in type 1 diabetes. By treating with GAD formulated as a vaccine, the patient's immune system is affected in such a way that it down regulates the attack on the insulin-producing cells. Stopping this autoimmune process is the cornerstone in curing type 1 diabetes.

Immunological analyses from the Phase II study as presented in the New England Journal of Medicine help to form an understanding of the Diamyd(R) vaccine's mechanism of action. A significant increase in regulatory T-cell activity was seen, which is considered decisive in counteracting the course of autoimmune diseases.

About the Phase II study:

The Phase II study now being presented comprised 70 patients aged 10-18 with type 1 diabetes. The patients, who received two injections of Diamyd(R), retained their own ability to pro
'/>"/>

SOURCE Diamyd Medical AB (publ)
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Diamyd(R) Diabetes Vaccine Receives Approval to Start Phase III Trials in Europe
2. Wild Blueberries Take Top Spot in New Antioxidant Research Study
3. National Study Presented at ACG 2008 Confirms New Device Functions Like Rear-View Mirror to Provide Improved View of the Colon
4. Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period
5. Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD
6. Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation
7. New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohns Disease According to First-of-its Kind Study
8. Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
9. Complete Genomics and the Institute for Systems Biology Announce Partnership to Conduct the First Human Genome Population Study
10. The Childrens Hospital of Philadelphia Announces New Regional Participant in The National Childrens Study
11. Xalieve(TM) Gains Momentum as Calabar AB Launches a Phase II Repeated Dose Study in Dry Mouth Patients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2009)...e/ -- This year at the Radiological Society of Nor...eeting, FUJIFILM Medical Systems USA is announcing...e with the introduction of Synapse(TM) 3D*. Fujif...essing by now offering its own advanced imaging ca...ovascular applications. The company has also made...
(Date:11/28/2009)...ire/ -- Siemens Healthcare redefines productivity...maging matrix) technology and with its new Dot(TM)...gies are introduced in the new MAGNETOM ® Ae...canners at the 95th Scientific Assembly and Annual...ica (RSNA) from November 29 to December 3 at McCor...
(Date:11/27/2009)... Booth - 3646/South Hall ... premier supplier of X-ray tubes and flat panel di... of detectors at the RSNA Annual Meeting in Chicag...an will also be exhibiting X-ray tube technology f...er treatment technologies. ,, Varian,s exhibit...
Breaking Medicine Technology:FUJIFILM Enters Advanced Visualization Market 2FUJIFILM Enters Advanced Visualization Market 3FUJIFILM Enters Advanced Visualization Market 4Siemens Introduces Its New Power Couple at RSNA 2009 2Siemens Introduces Its New Power Couple at RSNA 2009 3Siemens Introduces Its New Power Couple at RSNA 2009 4Siemens Introduces Its New Power Couple at RSNA 2009 5Siemens Introduces Its New Power Couple at RSNA 2009 6Siemens Introduces Its New Power Couple at RSNA 2009 7Varian Medical Systems to Highlight the Latest Digital Detectors, X-ray Tubes and Cancer Treatment Technology at the Radiological Society of North America (RSNA) Annual Meeting in Chicago 2More than just the tailpipe 8738 1More than just the tailpipe 8738 2Bacteria from the deep can clean up heavy metals 12500 1Death rates same for diabetes and heart disease patients receiving drug therapy or surgery 48111 1Death rates same for diabetes and heart disease patients receiving drug therapy or surgery 48111 2
...E: LLY ) has submitted a supplemental New Drug Ap...tration (FDA) seeking approval for a new,indicatio...ent of chronic,pain, the company announced today. ...ials in chronic osteoarthritis pain of the knee an...previously completed pain studies in,diabetic peri...
...ccessfully placed in three patient...May 29 Three patients with established,cardiac is... vProtect,Luminal Shield, a self-expanding intraco...y that typically occurs when stents are deployed. ...ort for the vessel to ensure that,the target coron...
Other Medicine Technology:Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration 2Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration 3Prescient Medical, Inc. Achieves Successful Clinical Debut of vProtect(TM) Luminal Shield 2
(Date:11/30/2009)... Firm uses Staten Island courtroom to recreate ...were 100% responsible for client’s accident.... November 30, 2009 -- A Staten Island, N.Y. jury a...aperhanger who was injured at a New York City cons... J.T. Magen Construction Company et al (Index No. ...
(Date:11/30/2009)...ELAND, Ohio, November 30 Simbionix... medical simulation systems, in collaboration,with...e Rehearsal Studio(TM),workshop for the first time...y. , The Simbionix PROcedure Rehearsal St... enable clinicians to create practice scenarios ba...
(Date:11/30/2009)...y is an effective, convenient technique that, when...cerous breast lesions from benign results, accordi...al meeting of the Radiological Society of North Am...us findings, physicians often use ultrasound to ob...as the potential to result in more biopsies becaus...
(Date:11/29/2009)... The Academy of General Dentistry (AGD) announc...eived the Mastership Award during the AGD,s commen...mmitment to excellence in dental education.,To ac... approved continuing dental education in the 16 di...ted to hands-on skills and techniques. , ...
(Date:11/29/2009)...00 round of treatment equals a $41,000 pay raise, ...ealthDay News) -- Psychological therapy may be muc...ng a raise or winning a lottery prize, suggests an...thousands of people who provided information about...se in happiness from a $1,329 course of therapy wa...
Breaking Medicine News(10 mins):Health News:Raphaelson & Levine Secures $1.1 Million Verdict for Victim of New York Construction Accident 2Health News:Simbionix First Procedure Rehearsal Studio(TM) Training Workshop 2Health News:Simbionix First Procedure Rehearsal Studio(TM) Training Workshop 3Health News:Elastography reduces unnecessary breast biopsies 2Health News:Orange County Dentist Honored by The Academy of General Dentistry 2Health News:Psychotherapy Can Boost Happiness More Than Money: Study 2
...ng court procedure and family disputes regarding t...heir toll on the actor's health , say his close fr...ied about Sanju's stress level. Anything can happe... his vertebrae have collapsed suddenly. Sanju had ...
...the city's health services panel Friday approved a...) fixed fine for anyone who breaches tough new ant...e to be drafted in to back up the teams of tobacco...c parks in Hong Kong on January 1 but offenders mu...
... has shown that a synthetic derivative of a common...oost the odds of living longer. Universit...t the compound derived from creosote is called NDG... normal diet and NDGA have so far been found to su...
...ers could appease your appetite and boost your lib...o chemically enhance the aphrodisiacal qualities o...rge May started feeding his oysters with the anti-...rwent surgery for prostate cancer. May cl...
...ns making a grand entry into Kerala, tourist resor...ing health packages. The rainy season, experts sa... Although Ayurveda evolved centuries ago in Indi...cording to ayurveda specialists, the monsoon seaso...
... The specialty oriented professional medical searc...ormation, today introduced SearchMedica Oncology,...l prioritize search results by publication date, m...ch engine at Chicago's McCormick Place, where onco...
Other Medicine News:Health News:Stress-Related Health Problems Haunts Sanjay Dutt 2Health News:Common Desert Shrub may Increase Longevity 2Health News:Now Viagra Oysters Could Appease Your Appetite and Boost Your Libido! 2Health News:Ayurveda Resorts in Kerala Gear Up for the Monsoon Season 2Health News:Ayurveda Resorts in Kerala Gear Up for the Monsoon Season 3Health News:CMPMedica Adds Oncology Search Engine to SearchMedica.com 2
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
Medicine Products: